Merck ’s MRK stock has declined around 10.3% in the past three months, losing almost $32 billion of its market value.

A letter from the FDA rejecting Merck Sharpe & Dohme Corp.'s proposed label warning that its osteoporosis drug Fosamax could cause stress fractures doesn’t preempt state law claims alleging the ...

Merck (MRK) ended the recent trading session at $117.17, demonstrating a -0.05% swing from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss of 0.19%.

That increase has boosted valuations, as the price-to-sales (P/S) ratio of 19 indicates that the stock is not cheap. Still, considering that ServiceNow's average P/S ratio over the last five years is ...

Shares of Bicara Therapeutics—a biopharmaceutical company backed by Indian billionaire Kiran Mazumdar-Shaw—surged about 42% ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

One simple Vanguard ETF, the Vanguard High Dividend Yield ETF (NYSEMKT: VYM), has the potential to turn a consistent ...

This week, the FDA approved Eli Lilly’s LLY eczema drug, Ebglyss (lebrikizumab), and the expanded use of Novartis’ NVS ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The growth of AI in the healthcare sector is already having real-world impacts and promises a step-change in future care.

Former NFL wide receiver Antonio Brown and former NFL player and Georgia U.S. Senate candidate Herschel Walker have endorsed Trump. The former president is also endorsed by boxer Jake Paul and U.S.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...